|
Volumn 14, Issue 5, 1997, Pages 639-642
|
The potential for heparin and its derivatives in the therapy and prevention of HIV-1 infection
|
Author keywords
AIDS; CD4; Dextran sulphate; gp120; Heparin; HIV 1; Human immunodeficiency virus; Sulphated polysaccharides; V3 loop
|
Indexed keywords
CD4 ANTIGEN;
DEXTRAN SULFATE;
GLYCOPROTEIN;
GLYCOPROTEIN GP 120;
HEPARIN;
HEPARIN DERIVATIVE;
POLYSACCHARIDE SULFATE;
RECOMBINANT PROTEIN;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANTICOAGULATION;
BINDING SITE;
CELL CULTURE;
CONFERENCE PAPER;
DRUG MECHANISM;
HUMAN;
HUMAN CELL;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
PRIORITY JOURNAL;
PROTEIN BINDING;
PROTEIN DOMAIN;
STRUCTURE ACTIVITY RELATION;
VIRUS REPLICATION;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ANTI-HIV AGENTS;
CD4-POSITIVE T-LYMPHOCYTES;
CELLS, CULTURED;
HEPARIN;
HIV ENVELOPE PROTEIN GP120;
HIV-1;
HUMANS;
VIRUS REPLICATION;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
|
EID: 0030790027
PISSN: 02820080
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1018596728605 Document Type: Conference Paper |
Times cited : (43)
|
References (26)
|